Pseudoephedrine Sulfate

硫酸伪麻黄碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePseudoephedrine Sulfate
Drug Alias NamePseudoephedrini SulfasAfrinol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonistsAdrenergic receptors alpha-2 agonistsBeta-1 adrenergic receptor agonists +[5] 
TargetsBeta-2 adrenergic receptorAdrenergic receptors alpha-1Adrenergic receptors alpha-2 +[5] 
Therapy Area/IndicationsRhinitis, AllergicNasal Obstruction
Global Approved IndicationsRhinitis, AllergicNasal Obstruction
Approved Indications in ChinaNasal Obstruction
Original Approved Country/TerritoryUnited States
Original Approved Date1980/10/30
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesQinghai Lake Pharmaceutical Co Ltd
Inactive CompaniesSchering - Plough Sa
Active IndicationsNasal Obstruction
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeR01BA02
Related LinksWikipediaDrugBankKEGG